Ku JL - Search Results

1

ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma.

Kim Y, You JH, Ryu Y, Park G, Lee U, Moon HE, Park HR, Song CW, Ku JL, Park SH, Paek SH. Kim Y, et al. Among authors: ku jl. NPJ Precis Oncol. 2024 Mar 28;8(1):79. doi: 10.1038/s41698-024-00566-1. NPJ Precis Oncol. 2024. PMID: 38548861 Free PMC article.

2

The telomere maintenance mechanism spectrum and its dynamics in gliomas.

Kim S, Chowdhury T, Yu HJ, Kahng JY, Lee CE, Choi SA, Kim KM, Kang H, Lee JH, Lee ST, Won JK, Kim KH, Kim MS, Lee JY, Kim JW, Kim YH, Kim TM, Choi SH, Phi JH, Shin YK, Ku JL, Lee S, Yun H, Lee H, Kim D, Kim K, Hur JK, Park SH, Kim SK, Park CK. Kim S, et al. Among authors: ku jl. Genome Med. 2022 Aug 11;14(1):88. doi: 10.1186/s13073-022-01095-x. Genome Med. 2022. PMID: 35953846 Free PMC article.

3

Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma.

Kim S, Park SJ, Chowdhury T, Hong JI, Ahn J, Jeong TY, Yu HJ, Shin YK, Ku JL, Park JB, Hur JK, Lee H, Kim K, Park CK. Kim S, et al. Among authors: ku jl. Cell Mol Life Sci. 2022 Mar 12;79(3):181. doi: 10.1007/s00018-022-04188-3. Cell Mol Life Sci. 2022. PMID: 35278143 Free PMC article.

4

Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide.

Choo M, Mai VH, Kim HS, Kim DH, Ku JL, Lee SK, Park CK, An YJ, Park S. Choo M, et al. Among authors: ku jl. Acta Pharmacol Sin. 2023 Mar;44(3):670-679. doi: 10.1038/s41401-022-00984-6. Epub 2022 Sep 13. Acta Pharmacol Sin. 2023. PMID: 36100765 Free PMC article.

5

Clinical characteristics of Peutz-Jeghers syndrome in Korean polyposis patients.

Choi HS, Park YJ, Youk EG, Yoon KA, Ku JL, Kim NK, Kim SM, Kim YJ, Moon DJ, Min JS, Park CJ, Bae OS, Yang DH, Jun SH, Chung ES, Jung PM, Whang Y, Park JG. Choi HS, et al. Among authors: ku jl. Int J Colorectal Dis. 2000 Feb;15(1):35-8. doi: 10.1007/s003840050005. Int J Colorectal Dis. 2000. PMID: 10766089 Review.

6

Induction of LGR5 by H2O2 treatment is associated with cell proliferation via the JNK signaling pathway in colon cancer cells.

Kim SH, Kim KH, Yoo BC, Ku JL. Kim SH, et al. Among authors: ku jl. Int J Oncol. 2012 Nov;41(5):1744-50. doi: 10.3892/ijo.2012.1596. Epub 2012 Aug 22. Int J Oncol. 2012. PMID: 22923033

7

Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines.

Ku JL, Park SC, Kim KH, Jeon YK, Kim SH, Shin YK, Noh DY, Im SA, Bang YJ, Han W, Kim WH, Park JG. Ku JL, et al. Int J Oncol. 2013 Dec;43(6):2073-81. doi: 10.3892/ijo.2013.2144. Epub 2013 Oct 18. Int J Oncol. 2013. PMID: 24141649

8

Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.

Moon HH, Kim SH, Ku JL. Moon HH, et al. Among authors: ku jl. Oncol Rep. 2016 Jan;35(1):298-306. doi: 10.3892/or.2015.4342. Epub 2015 Oct 21. Oncol Rep. 2016. PMID: 26497773

9

Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.

Seol MA, Kim JH, Oh K, Kim G, Seo MW, Shin YK, Sim JH, Shin HM, Seo BY, Lee DS, Ku JL, Han I, Kang I, Park SI, Kim HR. Seol MA, et al. Among authors: ku jl. Sci Rep. 2019 May 6;9(1):6917. doi: 10.1038/s41598-019-43294-4. Sci Rep. 2019. PMID: 31061414 Free PMC article.

10

SORBS1 serves a metastatic role via suppression of AHNAK in colorectal cancer cell lines.

Cho WC, Jang JE, Kim KH, Yoo BC, Ku JL. Cho WC, et al. Among authors: ku jl. Int J Oncol. 2020 May;56(5):1140-1151. doi: 10.3892/ijo.2020.5006. Epub 2020 Mar 5. Int J Oncol. 2020. PMID: 32319594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters